We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNST icon
1326
Renasant Corp
RNST
$4B
$209K ﹤0.01%
+6,173
New +$223K
AIR icon
1327
AAR Corp
AIR
$5.77B
$209K ﹤0.01%
+3,740
New +$248K
PRK icon
1328
Park National Corp
PRK
$3.75B
$208K ﹤0.01%
+1,375
New +$226K
HCI icon
1329
HCI Group
HCI
$2.32B
$208K ﹤0.01%
1,392
-330
-19% -$41.8K
SW
1330
Smurfit Westrock
SW
$26.2B
$202K ﹤0.01%
+4,488
New +$228K
NSC icon
1331
Norfolk Southern
NSC
$75.9B
$201K ﹤0.01%
+848
New +$207K
BLMN icon
1332
Bloomin' Brands
BLMN
$924M
$195K ﹤0.01%
+27,248
New +$289K
CGEN icon
1333
Compugen
CGEN
$228M
$188K ﹤0.01%
129,026
-188,474
-59% -$368K
ORMP icon
1334
Oramed Pharmaceuticals
ORMP
$182M
$186K ﹤0.01%
87,136
-19,926
-19% -$46K
KE
1335
Kimball Electronics
KE
$626M
$178K ﹤0.01%
10,795
-46,692
-81% -$826K
KRMD icon
1336
KORU Medical Systems
KRMD
$154M
$170K ﹤0.01%
66,917
+7,046
+12% +$26.2K
ENTA icon
1337
Enanta Pharmaceuticals
ENTA
$391M
$168K ﹤0.01%
30,465
+5,829
+24% +$36K
MEI icon
1338
Methode Electronics
MEI
$593M
$168K ﹤0.01%
26,347
-29,865
-53% -$295K
UAA icon
1339
Under Armour
UAA
$2.3B
$163K ﹤0.01%
+26,058
New +$194K
SD icon
1340
SandRidge Energy
SD
$516M
$154K ﹤0.01%
+13,503
New +$160K
ALTO icon
1341
Alto Ingredients
ALTO
$326M
$151K ﹤0.01%
132,604
-17,218
-11% -$26.6K
ARDX icon
1342
Ardelyx
ARDX
$1.01B
$144K ﹤0.01%
+29,324
New +$157K
TIGR
1343
UP Fintech Holding
TIGR
$833M
$144K ﹤0.01%
+16,709
New +$125K
MQ icon
1344
Marqeta
MQ
$1.71B
$143K ﹤0.01%
+8,698
New +$137K
AEO icon
1345
American Eagle Outfitters
AEO
$2.73B
$135K ﹤0.01%
+11,655
New +$167K
IMUX icon
1346
Immunic
IMUX
$226M
$131K ﹤0.01%
12,003
-3,914
-25% -$42.3K
NAVI icon
1347
Navient
NAVI
$867M
$129K ﹤0.01%
+10,191
New +$139K
ATOS icon
1348
Atossa Therapeutics
ATOS
$25.5M
$127K ﹤0.01%
12,621
BGS icon
1349
B&G Foods
BGS
$299M
$121K ﹤0.01%
+17,647
New +$118K
TRDA icon
1350
Entrada Therapeutics
TRDA
$290M
$104K ﹤0.01%
11,553
-74,068
-87% -$923K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.